As of 2026-06-15, the Relative Valuation of Ligand Pharmaceuticals Inc (LGND) is 168.58 USD. This relative valuation is based on P/E multiples. With the latest stock price at 255.54 USD, the upside of Ligand Pharmaceuticals Inc based on Relative Valuation is -34.0%.
The range of the Relative Valuation is 139.11 - 192.79 USD.
| Range | Selected | |
| Trailing P/E multiples | 21.5x - 25.2x | 24.6x |
| Forward P/E multiples | 21.0x - 24.2x | 22.4x |
| Fair Price | 139.11 - 192.79 | 168.58 |
| Upside | -45.6% - -24.6% | -34.0% |
| Date | P/E |
| 2026-06-12 | 33.35 |
| 2026-06-11 | 33.22 |
| 2026-06-10 | 32.40 |
| 2026-06-09 | 31.75 |
| 2026-06-08 | 31.03 |
| 2026-06-05 | 30.93 |
| 2026-06-04 | 30.79 |
| 2026-06-03 | 30.59 |
| 2026-06-02 | 30.38 |
| 2026-06-01 | 29.99 |
| 2026-05-29 | 30.27 |
| 2026-05-28 | 30.62 |
| 2026-05-27 | 30.78 |
| 2026-05-26 | 30.71 |
| 2026-05-22 | 29.93 |
| 2026-05-21 | 29.00 |
| 2026-05-20 | 28.42 |
| 2026-05-19 | 27.12 |
| 2026-05-18 | 27.13 |
| 2026-05-15 | 27.82 |
| 2026-05-14 | 28.58 |
| 2026-05-13 | 28.87 |
| 2026-05-12 | 28.97 |
| 2026-05-11 | 28.77 |
| 2026-05-08 | 28.89 |
| 2026-05-07 | 27.45 |
| 2026-05-06 | 30.35 |
| 2026-05-05 | 30.32 |
| 2026-05-04 | 29.80 |
| 2026-05-01 | 29.68 |
| 2026-04-30 | 29.94 |
| 2026-04-29 | 29.35 |
| 2026-04-28 | 30.32 |
| 2026-04-27 | 31.55 |
| 2026-04-24 | 30.18 |
| 2026-04-23 | 29.82 |
| 2026-04-22 | 29.61 |
| 2026-04-21 | 29.58 |
| 2026-04-20 | 30.25 |
| 2026-04-17 | 30.25 |
| 2026-04-16 | 29.13 |
| 2026-04-15 | 29.38 |
| 2026-04-14 | 30.32 |
| 2026-04-13 | 27.85 |
| 2026-04-10 | 26.74 |
| 2026-04-09 | 26.84 |
| 2026-04-08 | 27.16 |
| 2026-04-07 | 26.77 |
| 2026-04-06 | 26.57 |
| 2026-04-02 | 26.05 |